|
1.LASTS EVENTS 1.LASTS NEWS Medical Flashlight--12-08-2010 :Edité le 13 Aût 2010 Mineral and bone disease pattern in elderly haemodialysis Title patients An increasing ...  Medical Flashlight--22-07-2010 :Edité le 26 Juillet 2010 Variability of Creatinine Measurements in Clinical Laboratories: Results fromthe CRIC ...  Medical Flashlight--15-07-2010 :Edité le 15 Juillet 2010 Hospital treatment for fluid overload in the Medicare haemodialysis population Fluid ... 
1.LASTS REVIEUWS |
Page 123
Edité le 17 Juin 2010Medical Flashlight:18/06/2010 Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in
haemodialysis patients
In food, phosphorus is mostly associated with protein and is often added for different reasons, such as in food
additives. This study examined the mortality-predictability of dietary phosphorus intake and the dietary phosphorus
to protein ratio..............
Edité le 04 Juin 2010Medical Flashlight:03/06/2010 A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Tenecteplase for
Improvement of Hemodialysis Catheter Function: TROPICS
In this randomized, double-blind study, patients with dysfunctional tunneled HD catheters, defined as a BFR <300
ml/min at 250 mmHg pressure in the arterial line, received 1-hour intracatheter dwell with tenecteplase (2 mg) or
placebo. The primary endpoint was the percentage of patients with BFR ? 300 ml/min and an increase of
? 25 ml/min above baseline 30 minutes before and at the end of HD.............
Edité le 14 Mai 2010Medical Flashlight:14/05/2010 Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis
patients
Data were analysed from the CMS (Centers for Medicare & Medicaid Services) end stage renal disease database.
The cohort consisted of adult patients who initiated dialysis in 2003. The primary analysis was intention-to-treat
(ITT) survival by dialytic modality from initiation of dialysis (day 0). Secondary analyses included 1. survival analysis
from day 90, by modality at day 90; 2. as-treated analysis, with initial modality redefined at first modality switch at
60 days; and 3. subgroup analyses. 6337 patient pairs were matched from a cohort of 98,875 dialysis patients............ Page 123
|